echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Science: Is your sleep quality up to standard?

    Science: Is your sleep quality up to standard?

    • Last Update: 2022-05-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Introduction

    Introduction

    Multiple lines of evidence suggest that dopamine is involved in the regulation of sleep: drugs targeting dopamine signaling pathways can effectively regulate wakefulness; eliminating dopamine can reduce the duration of rapid eye movement sleep in mice; dopamine receptor type 2 (Drd2) agonists can promote rapid eye movement sleep


    In the report of the 19th National Congress of the Communist Party of China, the "Healthy China" development strategy was put forward.


    The Secret of Alternating Sleep Cycles: Dopamine Initiates REM Sleep

    The Secret of Alternating Sleep Cycles: Dopamine Initiates REM Sleep

    Recently, the research team of Takeshi Sakurai from the University of Tsukuba, Japan, based on the GRAB-DA dopamine fluorescent probe technology, revealed that dopamine acts on neurons expressing dopamine receptor D2 (Drd2) in the amygdala, which can induce rapid eye movement sleep, indicating that dopamine Signals play a key role in initiating REM sleep and provide the neuronal basis for the generation of sleep cycles


    Figure 1 Research results (Source: Science)

    Figure 1 Research results (Source: Science)

    GRAB-DA is a dopamine fluorescent probe that records the dynamics of the system through optical fiber to observe the sleep-wake phase in mice under the basolateral amygdala (BLA), nucleus accumbens (NAc), and internal prefrontal cortex (mPFC) nuclei Concentrations of dopamine in the lateral thalamic area (LHA) region


    ①In the BLA area, the non-REM sleep period transitions to the REM sleep period, and the dopamine level rises briefly and decreases during the REM sleep period;

    ①In the BLA area, the non-REM sleep period transitions to the REM sleep period, and the dopamine level rises briefly and decreases during the REM sleep period;

    ②In NAc, dopamine levels increased during the transition from non-REM sleep to REM sleep, and fluctuated slightly higher on average during REM sleep;

    ②In NAc, dopamine levels increased during the transition from non-REM sleep to REM sleep, and fluctuated slightly higher on average during REM sleep;

    ③ In the mPFC and LHA regions, during the transition from non-REM sleep to REM sleep, there was little change in dopamine levels and a significant decrease during REM sleep


    ③ In the mPFC and LHA regions, during the transition from non-REM sleep to REM sleep, there was little change in dopamine levels and a significant decrease during REM sleep


    ①In the non-REM sleep period, light-activated dopamine neurons in the BLA region promoted the mice to enter REM sleep briefly, indicating that the dopamine signal in the BLA region plays an important role in the mouse entering the REM sleep period;

    ②During non-REM sleep, light inhibited dopamine type 2 receptor (Drd2)-positive neurons in the BLA region, which promoted mice to enter REM sleep briefly


    Figure 2.


    Figure 2.


    This study shows the important role of dopamine signaling in BLA in regulating REM sleep, and also reveals the mechanism of cataplexy, which is expected to be a potential drug target for sleep disorders


    300 million Chinese people have sleep disorders, spawning a 100 billion-level sleep aid market

    The "China Sleep Research Report (2022)" shows that in the past 10 years, the per capita sleep time in China has been reduced from 8.


    1.


    1.


    With the continuous improvement of sleep health awareness, more and more consumers are willing to pay for high-quality sleep, and the sleep aid economic market is booming, and various sleep aid products have emerged as the times require


    The growing demand for sleep has also driven the rise of market segments.


    2.


    2.
    The sleep economy market is broad, and the future of pharmaceutical health products can be expected

    Today's fast-paced and stressful social life will inevitably lead to increasingly severe sleep problems.
    At the same time, the raging of the new coronavirus has made social emotions relatively tense.
    In this environment, sleep problems are even more prominent
    .
    Therefore, sleep problems will occupy a more prominent position in health management in modern life, and the gradual modernization of social life will also prompt Chinese people to pay more attention to sleep health
    .
    Long-term unhealthy sleep is likely to induce various other diseases, and timely drug treatment is required.
    Therefore, the potential of pharmaceutical health care products is worth looking forward to.
    Sleep drugs and health care product-related companies are expected to usher in market dividends
    .

    The symptoms of insomnia in some people are caused by other mental diseases.
    At this time, it cannot be treated only as a sleep problem.
    It may even involve the need for drugs for other mental diseases.
    Only symptomatic treatment can effectively solve the sleep problem
    .
    At present, the clinical drugs for the treatment of insomnia mainly include benzodiazepines? Receptor agonists (BZRAs), melatonin receptor agonists, orexin receptor antagonists, and antidepressants with hypnotic effects
    .
    BZRAs are classified as benzodiazepines? Drugs (BZDs) and non-benzodiazepines? Non-BZDs, the sales of these two types of drugs are increasing; Melatonin receptor agonists are also favored by consumers, and agomelatine is used more, and its sales volume and sales are both Showing a rapid growth trend; antidepressants have a sedative effect, so they also have a certain sleep aid effect, coupled with the increasing number of depression groups, they also have great potential for development
    .
    Therefore, at present, sleep aids will be promising
    .
    In addition, the market of sleep aids and health care products in China is in the initial stage of development, and the penetration rate is expected to increase rapidly
    .

     

    Original source:

    Original Source: Original Source:

    Hasegawa E, Miyasaka A, Sakuray K, et al.
    Rapid eye movement sleep is initiated by basolateral amygdala dopamine signaling in mice .
    Science.
    2022 Mar4;375(6584):994-1000.
    doi: 10.
    1126/science.
    abl6618.
    Epub 2022 Mar 3.
    PMID: 35239361.

    Hasegawa E, Miyasaka A, Sakuray K, et al.
    Rapid eye movement sleep is initiated by basolateral amygdala dopamine signaling in mice .
    Science.
    2022 Mar4;375(6584):994-1000.
    doi: 10.
    1126/science.
    abl6618.
    Epub 2022 Mar 3.
    PMID: 35239361.
    Rapid eye movement sleep is initiated by basolateral amygdala dopamine signaling in mice

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.